EyePoint(EYPT)
盘前16.951.03+6.47%09:15 EST
15.92-0.01-0.06%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称EyePoint所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况EyePoint, Inc.于2008年3月19日在特拉华州注册成立，是一家临床阶段的生物制药公司，致力于开发和商业化创新疗法，以帮助改善患有严重视网膜疾病的患者的生活。公司采用其专有的生物可降解Durasert E技术进行持续的眼内药物输送，从而解决了频繁玻璃体内注射带来的难题。其主要候选产品DURAVYU是一种用于治疗血管内皮生长因子介导的视网膜疾病的在研疗法。- 01-07Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-05Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-12-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-04Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-28Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-26Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-12Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-06Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-06Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-05Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-15Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses[补充]招股说明书Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-10-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-07Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
16.07
今开
15.93
量比
0.97
最低
15.64
昨收
15.93
换手率
1.46%